login
  Password reminder
Interventional News
Contact the editor Visit Interventional News Twitter feed Visit Interventional News Facebook page
 

Terumo introduces Azur Detachable 35 Peripheral Framing Coil


Monday, 02 Apr 2012 12:34
Azur coils
Azur coils

Terumo Interventional Systems, one of the leading manufacturers of guidewires, catheters, sheaths, and embolization products, has announced the US availability of the Azur D35 Framing Coil for peripheral embolization procedures.


Azur is indicated for peripheral embolization procedures where a scaffolding structure is needed, such as: hypogastric artery embolization; peripheral arteriovenous malformations and fistulas; endoleaks; visceral aneurysms; and venous applications. The detachable embolic platform forms a spherical 3-dimensional shape when deployed and is designed to control the first coil deployment, when a standard coil would not suffice due to high flow and high pressures.


“The new Azur D35 Framing Coils’ innovative technology offers interventional radiologists and vascular surgeons options in challenging, high-flow procedures,” said Chris Pearson, vice president, Marketing, Terumo Interventional Systems. “These detachable framing coils afford greater filling capacity, packing density, and mechanical occlusion, particularly in the treatment of high-flow and challenging blood vessels, vascular malformations, and aneurysms.”


“The detachable technology allows the physician to optimise the framing coil placement, creating support for subsequent coils,” said Pearson. “Azur D35 Hydrogel coils expand gradually upon exposure to blood, which provides improved volumetric filling allowing highly effective, targeted embolization.”




Add New Comment

Most popular


New varicose vein treatment available in Europe
Monday, 16 Feb 2015
VariClose is a new technique by which an incompetent saphenous vein is sealed through embolisation. New varicose vein treatment available in Europe

IN.PACT Admiral drug-eluting balloon receives FDA approval
Monday, 05 Jan 2015
In the IN.PACT SFA trial, the device demonstrated the lowest clinically-driven target lesion revascularisation rate (2.4%) ever reported for an interventional treatment of peripheral arterial disease ... IN.PACT Admiral drug-eluting balloon receives FDA approval

Medtronic completes acquisition of Covidien
Tuesday, 27 Jan 2015
Under the terms of the acquisition agreement, Medtronic Inc and Covidien plc are now combined under Medtronic plc. Medtronic completes acquisition of Covidien

Features


“We are helping surgeons operate on sicker patients”
Wednesday, 25 Feb 2015
Daniel B Brown, Vanderbilt-Ingram Cancer Center, Nashville, USA, puts together a 2015 checklist on the latest portal vein embolization developments for Interventional News readers. “We are helping surgeons operate on sicker patients”

SIR 2015: Take home new skills and perspectives from Atlanta
Thursday, 15 Jan 2015
Jafar Golzarian, SIR 2015’s programme chair, discusses some of the most exciting sessions from the Society of Interventional Radiology’s (SIR’s) upcoming Annual Scientific Meeting (28 February–5 M... SIR 2015: Take home new skills and perspectives from Atlanta

Profiles


Gao-Jun Teng
Thursday, 11 Dec 2014
In the future, will interventional radiology be a subspecialty of radiology, or surgery? asks Gao-J... Gao-Jun Teng

José Ignacio Bilbao Jaureguízar
Wednesday, 08 Oct 2014
“No matter what their future orientation, interventional radiologists involved in interventional ... José Ignacio Bilbao Jaureguízar

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions